氨己烯酸片价格是多少？怎么购买？

Vigabatrin is an oral drug that was developed in the 1980s. Vigabatrin is a synthetic derivative of gamma-aminobutyric acid (GABA). It increases the concentration of the inhibitory meridian mediator GABA in the brain by irreversibly inhibiting GABA aminotransferase. It can increase the level of GABA in the human brain as the activity of GABA aminotransferase continues to decrease rapidly, and there is an obvious dose-effect relationship. Studies have shown that after administration of this drug, the concentration of GABA in the brains of rodents and in the cerebrospinal fluid of humans increases, and the degree of increase is related to the dose. Vigabatrin was approved for marketing in the United States in 2009. Its indication is the treatment of epilepsy in which other anti-epileptic drugs are ineffective, especially partial seizures. Vigabatrin tablets can also treat infantile spasms (West syndrome, West syndrome).

Epilepsy is believed to be familiar to many people. The cause is relatively complex. Symptoms include disturbance of consciousness or loss of consciousness, sudden falling to the ground, twitching of limbs, looking up, and spitting at the mouth. Vigabatrin is administered orally. The maximum daily dosage for adults is 2-3g. It is appropriate to start taking it at 1g a day. Then, depending on the reaction after taking the drug, if the reaction is good, it can be increased by 0.5g every week, and finally reaches a daily dose of 2-3g.

Among pediatric patients, 135 children aged 2 months to 12 years old with intractable epilepsy were treated with vigabatrin tablets Vigabatrin, and the effective rate was 34%, of which 49% were effective for partial seizures and only half of that for generalized seizures. There were 13 cases of infantile spasms and 26 cases of Lennox-Gastaut syndrome. Symptomatic childhood spasticity is better treated than cryptogenic spasticity.

How much does vigabatrin tablets cost? How to buy? It is understood that vigabatrin tablets are only available in a few countries. The vigabatrin tablets (vigabatrin) produced by Sanofi in France are cost-effective. Its specifications are 500 mg

The incidence of visual field defects was high (approximately one third) in patients treated with Vigabatrin. This often occurs after several months to several years of using Vigabatrin. Visual field defects can be severe, which can have real consequences for the patient. Most patients with visual field loss have no obvious symptoms.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician. 

Recommended hot articles: